Helen Mann, MSc
Helen Mann, MSc
Global Product Statistician
AstraZeneca
Alderley Park
Macclesfield
United Kingdom
SK10 4TF
Papers:
14
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multi-study sub-analysis